Details for New Drug Application (NDA): 216963
✉ Email this page to a colleague
The generic ingredient in VASOPRESSIN is vasopressin. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 216963
Tradename: | VASOPRESSIN |
Applicant: | Gland Pharma Ltd |
Ingredient: | vasopressin |
Patents: | 0 |
Pharmacology for NDA: 216963
Physiological Effect | Decreased Diuresis Vasoconstriction |
Suppliers and Packaging for NDA: 216963
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 216963 | ANDA | Sagent Pharmaceuticals | 25021-474 | 25021-474-01 | 25 VIAL in 1 CARTON (25021-474-01) / 1 mL in 1 VIAL |
VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 216963 | ANDA | Gland Pharma Limited | 68083-520 | 68083-520-10 | 10 VIAL in 1 CARTON (68083-520-10) / 1 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20UNITS/ML (20UNITS/ML) | ||||
Approval Date: | Feb 9, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription